BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...

The choice was Jonathan Brand, a 25-year-old righthander who finished last season with Double A Portland. Brand had been added to the major league roster before for Grapefruit League games but had ...

An antibody-drug conjugate like Enhertu. However, some patients may not be eligible for or cannot tolerate ADCs. So once a patient is eligible for chemotherapy, PELA would be a natural fit as our ...

Not only are these ranked by capacity and performance, but we also dropped brands to the bottom that were legitimate fire hazards. In all, we recommend shopping for batteries on the bottom half of ...

Its breast cancer drug Trastuzumab Deruxtecan (brand name Enhertu), launched in January 2024, emerged as the top-selling new drug brand last year. According to IQVIA data, AstraZeneca had the ...

LOS ANGELES, March 06, 2025 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, is unveiling a bold new ...

"Daiichi Sankyo and AstraZeneca’s Enhertu shows OS improvements in Phase III trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on ...

Below, 112 Black-owned fashion brands to shop well beyond Black History Month. Happy shopping and supporting Black excellence! This brand brings a fun and fresh spin on classic wardrobe staples.

Credit: SewCreamStudio / Shutterstock. Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has shown clinically meaningful ‘improvement’ in the DESTINY-Gastric04 Phase III trial, ...